| Verity Resources Limited (VRL) ORDINARY FULLY PAID |
Materials |
$12 |
Exceptional Gold Met Recoveries Average 92.75% at Korong MRE
|
23 Jan 2026 9:04AM |
$0.024 |
$0.024 |
fallen by
0%
|
|
VRL - Price-sensitive ASX Announcement
Full Release
Key Points
- High gold recoveries averaging 92.75% at Korong.
- Best-case recoveries reached 98.1% for fresh high-grade material.
- Consistent performance across near-surface regolith domains.
- Low reagent consumption supports efficient processing.
- Results support conventional gravity and cyanide leaching methods.
- Testwork enhances confidence in mine planning and resource upgrade.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Strickland Metals Limited (STK) ORDINARY FULLY PAID |
Materials |
$579 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
23 Jan 2026 9:03AM |
$0.215 |
$0.220 |
risen by
2.33%
|
|
STK - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly activities during the December Quarter focused on drilling at Gradina, Shanac, and Kotlovi projects.
- Significant gold and zinc intercepts were identified, particularly at the Gradina site.
- The Company used a formula to calculate gold equivalent (AuEq) grades based on the prices and recovery rates of gold, copper, silver, lead, and zinc.
- The document includes intercept data for various drill holes such as ZRSD25208 and ZRSD25212, highlighting significant mineralization zones.
- Exploration at Shanac and Kotlovi also yielded notable results with high-grade gold and copper zones.
- The report provides detailed tables of significant intercepts and their corresponding grades for each project site.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$66 |
Notification of cessation of securities - NUZ
|
23 Jan 2026 9:02AM |
$0.084 |
$0.094 |
risen by
11.90%
|
|
| Miramar Resources Limited (M2R) ORDINARY FULLY PAID |
Materials |
$6 |
Change in substantial holding
|
23 Jan 2026 9:02AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$9 |
Emerging Growth Conference Presentation
|
23 Jan 2026 9:02AM |
$0.037 |
$0.029 |
fallen by
21.62%
|
|
| Liberty Metals Ltd (LIB) ORDINARY FULLY PAID |
Materials |
$29 |
HIGH-GRADE MONAZITE INDICATES DISTRICT-SCALE REE AT PARAIBA
|
23 Jan 2026 9:01AM |
$0.005 |
$0.004 |
fallen by
30%
|
|
LIB - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade monazite mineralization discovered in Paraiba.
- Significant concentrations of Neodymium and Praseodymium identified.
- Potential for district-scale rare earth element resources.
- Geological setting similar to successful models in Cameroon.
- Project located in established mineral sands region in Brazil.
- Further exploration and processing studies planned.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Guzman Y Gomez Limited (GYG) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,864 |
GYG announces Strategic Partnership with Uber
|
23 Jan 2026 9:01AM |
$22.440 |
$18.120 |
fallen by
19.25%
|
|
GYG - Price-sensitive ASX Announcement
Full Release
Key Points
- GYG announces an exclusive delivery partnership with Uber Eats.
- The partnership starts from 22 February 2026.
- Uber Eats will be GYG's exclusive delivery partner in Australia.
- The partnership aims to strengthen the delivery channel's economics.
- The exclusivity only applies to Australia.
- Delivery accounts for about 27% of GYG's total sales in Australia.
- 1H26 results will be released on 20 February 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,614 |
Net Tangible Asset Backing
|
23 Jan 2026 9:00AM |
$4.250 |
$4.130 |
fallen by
2.82%
|
|
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$88 |
Notice pursuant to Section 203D of the Corporations Act
|
23 Jan 2026 9:00AM |
$0.056 |
$0.080 |
risen by
42.86%
|
|
| Super Retail Group Limited (SUL) ORDINARY FULLY PAID |
Consumer Discretionary |
$3,087 |
Investor Conference Call Details for FY26 Half Year Results
|
23 Jan 2026 8:56AM |
$14.650 |
$13.670 |
fallen by
6.69%
|
|
| Apostle Dundas Global Equity Fund (ADEF) |
Financials |
$15 |
Monthly Factsheet - December 2025
|
23 Jan 2026 8:56AM |
$6.300 |
$5.610 |
fallen by
10.95%
|
|
| Sky Metals Limited (SKY) ORDINARY FULLY PAID |
Materials |
$183 |
Quarterly Cashflow Report - December 2025
|
23 Jan 2026 8:54AM |
$0.165 |
$0.185 |
risen by
12.12%
|
|
SKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Sky Metals Limited reported a net cash outflow from operating activities of $449,000 for the current quarter.
- Investing activities resulted in a net cash outflow of $1,464,000, primarily due to significant exploration and evaluation expenditures.
- Financing activities provided a net cash inflow of $592,000, largely from the issuance of equity securities.
- The company ended the period with cash and cash equivalents of $4,701,000.
- Payments to related parties included $54,000 for directors and consulting fees.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,467 |
Update - Notification of buy-back - FLT
|
23 Jan 2026 8:53AM |
$15.500 |
$11.610 |
fallen by
25.10%
|
|
| Franklin Australian Absolute Return Bond Fund (Managed Fund) (FRAR) |
Financials |
$721 |
Indicative Distribution Calendar 31 January 2026
|
23 Jan 2026 8:52AM |
$1.045 |
$1.045 |
fallen by
0%
|
|
| Delta Lithium Limited (DLI) ORDINARY FULLY PAID |
Materials |
$154 |
Lithium Exploration Update
|
23 Jan 2026 8:52AM |
$0.290 |
$0.215 |
fallen by
25.86%
|
|
DLI - Price-sensitive ASX Announcement
Full Release
Key Points
- Mt Ida project contains advanced lithium, tantalum, and rubidium resources.
- Total JORC MRE at Mt Ida is 14.8Mt at 1.2% Li2O.
- Successful production of 99.8% lithium carbonate from Mt Ida mica concentrate.
- Yinnetharra Lithium Project spans over 2,300 km².
- Yinnetharra MRE is 21.9Mt at 1.0% Li2O.
- Current exploration programs are ongoing with significant lithium intercepts.
- Delta's cash balance is $54 million as of 31 December 2025.
- Additional investments valued at $145 million as of 20 January 2026.
- Continued focus on exploration and development in Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$135 |
Quarterly Activities Report and Appendix 4C
|
23 Jan 2026 8:52AM |
$0.935 |
$0.550 |
fallen by
41.18%
|
|
NYR - Price-sensitive ASX Announcement
Full Release
Key Points
- HREC approval received for Phase IIa clinical trial of Xolatryp®.
- Patient recruitment for clinical trial to start in March 2026.
- AU$7.12 million cash balance as of 31 December 2025.
- Expected R&D tax rebate of AU$2.16 million for FY2025.
- Phase IIa trial to assess safety and preliminary efficacy in heart attack patients.
- Initiation of preclinical studies for oncology indications.
- Trademark granted for Xolatryp in medicinal and health services.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arovella Therapeutics Limited (ALA) ORDINARY FULLY PAID |
Health Care |
$91 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
23 Jan 2026 8:51AM |
$0.090 |
$0.075 |
fallen by
16.67%
|
|
ALA - Price-sensitive ASX Announcement
Full Release
Key Points
- Cash and cash equivalents at 31 December of $19.4 million.
- IND application for ALA-101 submitted to U.S. FDA.
- Preparation for first-in-human phase 1 trial for ALA-101 initiated.
- Demonstrated activity of CLDN18.2-targeting CAR for ALA-105.
- In-licensing additional CAR targets and technology from Baylor College of Medicine.
- Appointment of Dr. Andrew Nash as a Non-Executive Director.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$1,431 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
23 Jan 2026 8:50AM |
$1.665 |
$1.455 |
fallen by
12.61%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC Therapeutics Limited is a precision medicine company focusing on RNA therapeutics.
- The company is developing drug candidates for diseases like Polycystic Kidney Disease, Autosomal Dominant Optic Atrophy, Retinitis Pigmentosa type 11, and Phelan-McDermid Syndrome.
- The company's vision is to create life-changing impact for patients with genetic diseases.
- PYC reported a net cash outflow from operating activities of AUD 13,760,000 for the quarter.
- As of 31 December 2025, PYC had cash and cash equivalents of AUD 120,692,000.
- The company has four drug candidates with three already in human trials.
- PYC expects to complete significant clinical trials and regulatory steps by 2026.
- Payments to related parties in the quarter amounted to AUD 128,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bounty Oil & Gas NL (BUY) ORDINARY FULLY PAID |
Energy |
$4 |
Board and Management Renewal
|
23 Jan 2026 8:50AM |
$0.003 |
$0.003 |
fallen by
16.67%
|
|
BUY - Price-sensitive ASX Announcement
Full Release
Key Points
- Kane Marshall appointed as Independent Non-Executive Director and Chairman.
- Robin Armstrong appointed as Independent Non-Executive Director.
- Retirement of Non-Executive Directors Graham Reveleigh and Charles Ross.
- Retirement of CEO Philip Kelso.
- Focus on strengthening leadership for asset development and new ventures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Korvest Ltd (KOV) ORDINARY FULLY PAID |
Industrials |
$183 |
Investor Presentation
|
23 Jan 2026 8:48AM |
$14.300 |
$15.500 |
risen by
8.39%
|
|
KOV - Price-sensitive ASX Announcement
Full Release
Key Points
- Korvest Ltd (ASX:KOV) is headquartered in South Australia and provides cable and pipe supports along with galvanising services.
- The company experienced revenue and earnings growth compared to the previous corresponding period (PCP).
- Korvest has a solid pipeline of major infrastructure projects secured for the second half of FY26 and beyond.
- Significant project work expansion is noted, with both major and small projects increasing compared to PCP.
- The company successfully transitioned its ERP system and completed major upgrades to its galvanising operations, including a new kettle and burner management system.
- Korvest's Kilburn expansion is underway, focusing on factory automation and increased capacity.
- Dividend distribution includes a consistent interim dividend of 25¢ per share and a final dividend of 40¢, with a special dividend of 10¢ for FY26.
- The company has a national sales and warehouse network and a strong overseas supply chain, providing flexibility in make vs buy decisions.
- Korvest is focusing on growth in day-to-day and small project markets, as well as infrastructure, data centre, and large project pipelines.
- FY26 capital expenditure focuses on new equipment for enhanced capability and capacity, including development at Kilburn and a new Brisbane site.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| American Tungsten and Antimony Ltd (AT4) ORDINARY FULLY PAID |
Materials |
$159 |
AT4 SIGNS WITH DEUTSCHE BANK FOR NASDAQ LISTING
|
23 Jan 2026 8:48AM |
$0.165 |
$0.120 |
fallen by
27.27%
|
|
AT4 - Price-sensitive ASX Announcement
Full Release
Key Points
- American Tungsten & Antimony Ltd (AT4) is advancing towards a proposed listing on Nasdaq.
- Deutsche Bank has been appointed as the depositary for an American Depositary Receipt (ADR) program.
- The ADR program will allow US investors to acquire ADRs, accessible initially in the over-the-counter market and later on Nasdaq.
- The company aims to submit a confidential registration statement on Form 20-F to the US SEC in March 2026, with an anticipated listing on Nasdaq in Q2 2026.
- Graeme Morissey has been appointed as the new Chief Financial Officer.
- The Nasdaq listing is expected to provide access to the world's largest equity capital markets, aligning with growing interest in critical minerals in the US.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Korvest Ltd (KOV) ORDINARY FULLY PAID |
Industrials |
$183 |
Press Release 1H FY26 Results
|
23 Jan 2026 8:47AM |
$14.300 |
$15.500 |
risen by
8.39%
|
|
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$5,867 |
Ceasing to be a substantial holder
|
23 Jan 2026 8:46AM |
$7.270 |
$6.210 |
fallen by
14.58%
|
|
| Clover Corporation Limited (CLV) ORDINARY FULLY PAID |
Materials |
$130 |
Notification of buy-back - CLV
|
23 Jan 2026 8:44AM |
$0.770 |
$0.780 |
risen by
1.30%
|
|
| Clover Corporation Limited (CLV) ORDINARY FULLY PAID |
Materials |
$130 |
On-Market Acquisition of shares by Employee Share Plan trust
|
23 Jan 2026 8:44AM |
$0.770 |
$0.780 |
risen by
1.30%
|
|
CLV - Price-sensitive ASX Announcement
Full Release
Key Points
- On-market acquisition of up to 3,264,167 shares by Employee Share Plan Trust.
- Acquisition to align employee performance with shareholder interests.
- Acquisition will avoid dilution of existing shareholders.
- Approval was obtained at AGM on 18 November 2025.
- Shares to be acquired at a price not more than 5% above the 10-day VWAP.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
